• 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2021-03
  • 2020-08
  • 2020-07
  • 2020-03
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • br these medications within the study cohort


    these medications within the study cohort however may have limited any observation of potential benefit such medications may offer to reduce cancer therapy related cardiotoxicity [24–26].
    5. Conclusions
    In breast cancer patients CAC detected co-incidentally on CT chest predicted cardiac events. The findings of the study highlight that despite a life changing cancer diagnosis, attention to cardiovascular risk factors is important, for although cancer is a significant co-morbidity, coronary atherosclerosis remains a long-term determinant of cardiac clinical events. Prospective clinical studies with larger patient numbers would be useful to further clarify the utility of prediction tools such as FRS and CAC to assess cardiac risk prediction in cancer patients.
    Supplementary data to this Protease Inhibitor Cocktail article can be found online at https://doi.
    This project was funded by a University of Ottawa Faculty of Medicine scholarship.
    Conflict of interest
    The authors report no relationships that could be construed as a conflict of interest.
    [2] H.S. Hecht, P. Cronin, M.J. Blaha, M.J. Budoff, E.A. Kazerooni, J. Narula, et al., 2016 SCCT/STR guidelines for coronary artery calcium scoring of noncontrast noncardiac chest CT scans: a report of the Society of Cardiovascular Computed Tomography and Society of Thoracic Radiology, J. Thorac. Imaging 32 (5) (2017 Sep) W54–W66.
    [5] T.J. Anderson, J. Gregoire, R.A. Hegele, P. Couture, G.B. Mancini, R. McPherson, et al., 2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult, Can. J. Cardiol. 29 (2) (2013 Feb) 151–167.
    [12] S. Uretsky, N. Chokshi, T. Kobrinski, S.K. Agarwal, J.R. Po, H. Awan, et al., The inter-play of physician awareness and reporting of incidentally found coronary artery calcium on the clinical management of patients who underwent noncontrast chest computed tomography, Am. J. Cardiol. 115 (11) (2015 Jun 1) 1513–1517.
    [14] S.A. Gernaat, I. Isgum, B.D. de Vos, R.A. Takx, D.A. Young-Afat, N. Rijnberg, et al., Automatic coronary artery calcium scoring on radiotherapy planning CT scans of
    breast cancer patients: reproducibility and association with traditional cardiovascu-lar risk factors, PLoS One 11 (12) (2016), e0167925. .
    [15] L. Azour, M.A. Kadoch, T.J. Ward, C.D. Eber, A.H. Jacobi, Estimation of cardiovascular risk on routine chest CT: ordinal coronary artery calcium scoring as an accurate predictor of Agatston score ranges, J. Cardiovasc. Comput. Tomogr. 11 (1) (2017 Jan) 8–15.
    [20] N.J. Stone, J.G. Robinson, A.H. Lichtenstein, C.N. Bairey Merz, C.B. Blum, R.H. Eckel, et al., 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, J. Am. Coll. Cardiol. 63 (25 Pt B) (2014 Jul 1) 2889–2934.
    [21] M.F. Piepoli, A.W. Hoes, S. Agewall, C. Albus, C. Brotons, A.L. Catapano, et al., 2016 European guidelines on cardiovascular disease prevention in clinical practice: the Sixth Joint Task Force of the European Society of Cardiology and other societies on  cardiovascular disease prevention in clinical practice (constituted by representa-tives of 10 societies and by invited experts) developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR), Eur. Heart J. 37 (29) (2016 Aug 1) 2315–2381.
    Available online at
    Comparison of Laparoscopic and Open Approach in Treating Gallbladder Cancer
    Changzhou First People’s Hospital, The Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu, China